Holiday plan for carotid stent coverage
This article was originally published in The Gray Sheet
Medicare national coverage would extend to carotid stent patients at high risk in surgery, and who experience "symptomatic narrowing of the carotid artery of 70% or more," according to CMS' Dec. 17 proposal. In October, Medicare initiated coverage of the technology for FDA-required, post-approval studies (1"The Gray Sheet" Oct. 11, 2004, p. 5). Effective immediately, CMS also will expand insulin pump coverage for diabetics...
You may also be interested in...
CMS is calling on interventionalists, radiologists and surgeons to collaborate on carotid stenting training and credentialing requirements
Can Atlas Biomed unlock Japan's self-care market with its direct-to-consumer DNA and microbiome tests? HBW Insight catches up with the company's co-founder and CEO to discuss this and also how Atlas has been driving its European expansion plans despite coronavirus.
France's ANSES warns women using oral contraceptives not to use a supplement marketed by UK firm Hairburst after linking the product's consumption to two cases of severe acute hepatitis.